Log In
Print
BCIQ
Print
Print this Print this
 

aHUS Genetic Panel

  Manage Alerts
Collapse Summary General Information
Company Machaon Diagnostics Inc.
DescriptionGenetic test that detects 150 known or suspected mutations, deletions and polymorphisms associated with atypical hemolytic uremic syndrome (aHUS)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics: Personal genomics testing
Latest Stage of DevelopmentMarketed
Standard IndicationHematology, Diagnostic
Indication DetailsConfirm atypical Hemolytic Uremic Syndrome (aHUS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today